OICHARTS
8 AMThe 8 AM report →

THYROCARE

Thyrocare Technologies Limited · NSE · INE594H01019 · 272 sessions on record
₹533.60▼ −0.55 · −0.1%from ₹534.15 the session before · 1 Oct 2026 close · NSE end of day
Open
₹531.80
High
₹538.55
Low
₹519.30
Day's range
₹193.6% of the previous close
VWAP
₹528.70close +0.93% from it
Volume, shares
2.2 L0.95× the 20-session average
Turnover, ₹ crore
12
Trades
21,00011 shares per trade
Previous close
₹534.15−0.55 to the close
Price band, next session
₹480.25 – ₹586.9510% either side of the close · dynamic, widened in 5% steps when hit
Day range74% of the way up
₹519.30₹538.55
52-week range15% of the way up
₹342.55 23 Mar₹1,610.00 18 Nov

−67% from the high · +56% from the low

Futures and options

No derivatives listed on THYROCARE

Close ₹ · Nifty 50 rebased to the first close · futures open interest by the day's build-up126 sessions to 1 Oct · axis fixed at 4 × ATR-14 around the last close
272 sessions on file · from 28 Aug
THYROCARE close and futures open interest over the last 126 sessions, with Nifty 50 rebased to the first close357.89503.62649.35axis spans 81%Nifty 50THYROCARE1 Apr6 Jul1 Oct126 sessions from 1 Apr to 1 Oct; the price axis spans 81 percent.

The market after the news

close against the last close before each bulletin · Nifty 50 over the same sessions

After the last 5 bulletins, THYROCARE closed higher five sessions later in 0 of 5.

Close after each bulletin on the day, one session later and five sessions later, with Nifty 50 and futures open interest
BulletinDay of the news1 session later5 sessions laterFutures OI on the day
18 AugAPI Holdings repays ₹1,050 cr, releases Thyrocare shares▼ −4.2%Nifty −0.3% · −3.9 pp▼ −6.8%Nifty +0.3% · −7.2 pp▼ −0.5%Nifty +0.2% · −0.7 pp—
18 AugAPI Holdings repays ₹1,050 cr, frees Thyrocare shares▼ −1.7%Nifty −0.6% · −1.1 pp▼ −5.8%Nifty −0.9% · −5.0 pp▼ −3.6%Nifty +0.2% · −3.8 pp—
15 AugDocon sells 9.9% stake in Thyrocare for ₹986 crore▼ −0.9%Nifty −0.3% · −0.6 pp▼ −2.5%Nifty −0.9% · −1.7 pp▼ −6.4%Nifty −0.6% · −5.8 pp—
28 NovThyrocare Technologies bonus issue deadline is today▼ −66.4%Nifty −0.1% · −66.3 pp▼ −67.1%Nifty −0.1% · −67.0 pp▼ −72.2%Nifty −0.1% · −72.1 pp—
23 NovHDFC AMC and Thyrocare to trade ex-bonus next week▼ −4.3%Nifty −0.4% · −3.9 pp▼ −2.7%Nifty −0.7% · −2.0 pp▼ −68.4%Nifty +0.4% · −68.8 pp—
5 of 5 bulletins

Quarterly results

consolidated · latest filed 23 Jul, 06:59 pm IST · NSE filings

Revenue ₹240 cr; profit ₹51 cr in the Jun 2026 quarter, consolidated.

Last 2 quarters, consolidated₹ crore as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, Nifty 50 over the same session
Quarterly results of THYROCARE on the consolidated basis with the market's move on the first session after each filing
QuarterRevenue ₹ crRevenue YoYProfit ₹ crProfit YoYEPS ₹Market on the day
Jun 2026filed 23 Jul₹240 cr—₹51 cr—3.22▲ +3.5%Nifty −0.4% · +3.9 pp
Mar 2026filed 7 May · audited₹224 cr—₹49 cr—2.98▲ +3.4%Nifty −0.6% · +4.0 pp

Fundamentals

consolidated · filings to Jun 2026 · close ₹533.60 on 1 Oct

14 times book value, a 2.6% dividend yield, market cap ₹8,500 cr.

Valuationarithmetic on filings and the close · each cell names what it rests on · — where an input is missing
Market cap
₹8,500 cron 1 Oct · free float ₹3,300 cr
Price to earnings
—fewer than four consecutive quarters filed
Trailing EPS
—fewer than four consecutive quarters filed
Price to book
14consolidated · balance sheet to Mar 2026
Book value a share
₹36.82consolidated · balance sheet to Mar 2026 · over NSE's share count
Debt to equity
0.00borrowings over equity · consolidated · balance sheet to Mar 2026
Return on equity
—needs two filed balance sheets
Dividend yield
2.6%₹14.00 a share in 365 days
Face value
₹10a share
Shares outstanding
16 cron 1 Oct
Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated
Revenue, trailing 12 months
—fewer than four consecutive quarters filed
Revenue growth, 12 months
—needs eight consecutive quarters filed
Revenue 3-year CAGR
—needs twelve consecutive quarters filed
Profit, trailing 12 months
—fewer than four consecutive quarters filed
Profit growth, 12 months
—needs eight consecutive quarters filed
Profit 3-year CAGR
—needs twelve consecutive quarters filed
PeersBSE sub-group Healthcare Service Provider · F&O stocks with filings on record · industry P/E needs two stocks with trailing profit and a market cap
Stocks in the BSE sub-group Healthcare Service Provider with market cap, price to earnings and price to book
StockMarket cap ₹P/EP/BClose ₹
LALPATHLABDr. Lal Path Labs Ltd.34,000 cron 1 Oct—13₹2,005.10
VIJAYAVijaya Diagnostic Centre Limited15,000 cron 1 Oct—15₹1,428.00
METROPOLISMetropolis Healthcare Limited11,000 cron 1 Oct—7.3₹537.90
THYROCAREThyrocare Technologies Limited8,500 cron 1 Oct—14₹533.60
NEPHROPLUSNephrocare Health Services Limited6,500 cron 1 Oct—5.8₹648.95
SURAKSHASuraksha Diagnostic Limited1,800 cron 1 Oct—7.5₹350.15
KRSNAAKrsnaa Diagnostics Limited1,800 cron 1 Oct—1.8₹554.85
3BBLACKBIO3B Blackbio Dx Limited1,400 cron 1 Oct——₹1,646.80
ONEGLOBALOne Global Service Provider Limited1,000 cron 1 Oct——₹525.40
HEALTHXHealth X Platform Limited870 cron 1 Oct—1.1₹273.00
GAUDIUMIVFGaudium IVF and Women Health Limited800 cron 1 Oct—5.2₹109.50

Shareholding

quarter to 30 Jun · 100% of the promoter holding pledged · NSE filings

Promoters hold 60.9%, foreign portfolio investors 5.4%, mutual funds 19.9% and insurance companies 0.1%, as filed for the quarter to 30 Jun.

By category, last 2 quarterspercent of shares · beneath each figure, the change in percentage points against the previous quarter on file
Shareholding of THYROCARE by category over the last 2 quarters with the change against the previous quarter
Category30 Jun31 Mar
Promoters60.920.00 pp60.92
Foreign portfolio investors5.43▲ +0.06 pp5.37
Mutual funds19.86▲ +0.41 pp19.45
Insurance companies0.12▼ −0.25 pp0.37
Banks and financial institutions0.94▼ −0.24 pp1.18
Individual investors11.12▲ +0.17 pp10.95
Bodies corporate0.95▼ −0.16 pp1.11
Others0.66▲ +0.01 pp0.65

Corporate actions

NSE and BSE records

Nothing upcoming on record; the last was a dividend of ₹7.00 a share, ex-date 23 Jun 2026.

Actionsex-dates · upcoming first, then the last eight · dividends in rupees a share, bonus and split as ratios
Corporate actions of THYROCARE, upcoming first, then the most recent
Ex-dateActionAmount or ratioRecord dateSource
recent
23 Jun 2026dividend₹7.0023 Jun 2026NSE
28 Nov 2025bonus2:128 Nov 2025NSE
24 Oct 2025dividend₹7.0024 Oct 2025NSE
25 Jul 2025dividend₹21.0025 Jul 2025NSE
16 Aug 2024dividend₹18.0016 Aug 2024NSE
Calendaras notified to the exchange
Next results
—no board meeting notified yet
Dividends in 365 days
₹14.00a share · ex-dates inside the year
Last dividend
₹7.00ex-date 23 Jun 2026

Price history

272 sessions on record · to 1 Oct · NSE end of day

THYROCARE is −7.5% over 20 sessions against Nifty's −6.2%, 67% below its 52-week high, realised volatility 24% annualised.

Returns against Nifty 50longest window first · Nifty 50 over the same sessions
Returns of the stock and Nifty 50 over six windows, longest first
WindowFrom ₹THYROCARE %Nifty 50 %Difference pp
250 sessionssince 26 Sept₹1,124.32▼ −53%▼ −9.1%−43
120 sessionssince 9 Apr₹392.90▲ +36%▼ −5.7%+42
60 sessionssince 8 Jul₹521.71▲ +2.3%▼ −6.1%+8.4
20 sessionssince 2 Sept₹576.74▼ −7.5%▼ −6.2%−1.2
5 sessionssince 24 Sept₹566.76▼ −5.8%▼ −2.8%−3.1
1 sessionsince 30 Sept₹534.13▼ −0.10%▼ −0.88%+0.78
Averages of the closeclose against each average
5-session average
₹546.00close −2.3% from it
20-session average
₹559.60close −4.6% from it
50-session average
₹580.46close −8.1% from it
200-session average
₹482.33close +11% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
₹173.1% of the close
Average day's range, 20
₹142.7% of the close
Volume against 20 sessions
0.95×2.2 L vs 2.3 L average
Volatility and co-movement with Nifty 50annualised from daily log returns · counts share one denominator per cell
Realised volatility, 20
24%≈ ±1.5% a session · moved more than that on 5 of 20
Realised volatility, 60
39%≈ ±2.5% a session · moved more than that on 18 of 60
Realised volatility, 250
120%≈ ±7.3% a session · moved more than that on 2 of 250
Beta to Nifty, 60
0.37moved with Nifty on 33 of 60 sessions
Beta to Nifty, 250
0.55moved with Nifty on 139 of 250 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
5 up · 15 downof 20
Last 60 sessions
24 up · 36 downof 60
Last 250 sessions
116 up · 134 downof 250
Best session, 250
▲ +7.3%6 May
Worst session, 250
▼ −66%28 Nov

Thyrocare Technologies Limited is in 3 NSE indices

5 bulletins on THYROCARE

latest 18 Aug 2026

Beats in the coverage

Often mentioned with

August 2026

API Holdings repays ₹1,050 cr, releases Thyrocare sharesAPI Holdings repaid ₹1,050 cr in outstanding debt, funded by a stake sale in Thyrocare. This repayment released 51.02% of Thyrocare shares from pledge, enhancing financial flexibility and market confidence.High API Holdings repays ₹1,050 cr, frees Thyrocare sharesAPI Holdings repaid ₹1,050 cr in debt, freeing Thyrocare shares from pledge. The repayment was funded through stake sales in Thyrocare Technologies, enhancing API's financial position and investor confidence in the digital healthcare sector.High Docon sells 9.9% stake in Thyrocare for ₹986 croreDocon Technologies sold a 9.9% stake in Thyrocare Technologies for ₹986 crore, reducing its holding to 51.02%. The sale involved 1.57 crore shares at prices between ₹624 and ₹631.71, leading to a 3% rise in Thyrocare's share price.High

November 2025

Thyrocare Technologies bonus issue deadline is todayMedium HDFC AMC and Thyrocare to trade ex-bonus next weekMedium

About Thyrocare Technologies Limited

exchange masters as of 18 Sept 2026 · classification by BSE
Company
Thyrocare Technologies Limited
Exchange
NSE · BSE 539871, group A
Listed on NSE
9 May 2016
Classification
Healthcare › Healthcare Services › Healthcare Service Provider
Index
BSE 1000
Face value
₹10 a share
ISIN
INE594H01019
Sessions on record
272
Price source
NSE UDiFF bhavcopy · end of day · delayed
Filings
NSE and BSE public disclosures · results, shareholding and corporate actions as filed
Computed
1 Oct, 10:08 pm IST
Bulletins
5 · written by the desk · not a recommendation

OI Charts is not a SEBI-registered investment adviser or research analyst. Prices, open interest, filings and the desk read are exchange data and arithmetic on it, not a basis for any investment decision.